Rayzebio Inc (RYZB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RYZB | IMVT | BHVN | ||
| Company | Rayzebio Inc | Immunovant Inc | Biohaven Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 62.49 | 25.44 | 34.85 | ||
| High | 62.50 | 26.27 | 36.95 | ||
| Low | 62.48 | 25.25 | 34.46 | ||
| Last | 62.49 | 25.86 | 36.26 | ||
| Change | +0.01 | +0.20 | +0.92 | ||
| % Change | +0.02% | +0.78% | +2.60% | ||
| Volume | 282,700 | 3,237,200 | 3,229,100 | ||
| 20-Day Average Volume | 318,060 | 952,020 | 1,116,810 | ||
| Previous Close | 62.48 | 25.66 | 35.34 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 62.28 | 27.71 | 42.43 | ||
| 20-Day Raw Stochastic | 95.83% | 14.39% | 13.54% | ||
| 20-Day Relative Strength | 86.10% | 41.02% | 35.84% | ||
| Weighted Alpha | N/A | -35.73 | -17.41 | ||
| Today's Opinion | N/A | 88% Sell | 40% Sell | ||
| Previous Opinion | N/A | 88% Sell | 40% Sell | ||
| Last Month's Opinion | N/A | 88% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.13% since 02/15/24 | -1.60% since 12/13/24 | -5.74% since 12/13/24 | ||
| Low | 62.42 on 02/16/24 | 25.25 on 12/20/24 | 34.46 on 12/20/24 | ||
| High | 62.51 on 02/22/24 | 28.08 on 12/17/24 | 42.13 on 12/16/24 | ||
| 1-Month | |||||
| %Chg | +0.87% since 01/23/24 | -1.18% since 11/20/24 | -22.57% since 11/20/24 | ||
| Low | 61.86 on 01/24/24 | 25.25 on 12/20/24 | 34.46 on 12/20/24 | ||
| High | 62.51 on 02/22/24 | 29.49 on 12/09/24 | 47.75 on 11/27/24 | ||
| 3-Month | |||||
| %Chg | +167.05% since 11/22/23 | -11.53% since 09/20/24 | -10.23% since 09/20/24 | ||
| Low | 22.14 on 11/27/23 | 24.61 on 11/19/24 | 34.46 on 12/20/24 | ||
| High | 62.51 on 02/22/24 | 32.10 on 11/06/24 | 55.70 on 10/08/24 | ||
| 6-Month | |||||
| %Chg | N/A since 09/15/23 | -5.24% since 06/20/24 | +8.43% since 06/20/24 | ||
| Low | 17.95 on 09/26/23 | 24.61 on 11/19/24 | 32.50 on 08/05/24 | ||
| High | 62.51 on 02/22/24 | 34.47 on 09/06/24 | 55.70 on 10/08/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,744,400 | 3,795,860 | 3,666,684 | ||
| Shares Outstanding, K | 59,920 | 146,785 | 101,122 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -68,600,000 | -259,340,000 | -408,170,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -18,190,000 | -109,120,000 | -160,300,000 | ||
| 60-Month Beta | N/A | 0.64 | 1.24 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.26 on 11/13/23 | -0.74 on 11/07/24 | -1.70 on 11/12/24 | ||
| Latest Earnings Date | 03/04/24 | 02/10/25 | 11/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||